Office for Civil Rights; Statement of Delegation, 2804 [2018-00818]
Download as PDF
<![CDATA[
2804
Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Office of the Secretary
National Institutes of Health
Office for Civil Rights; Statement of
Delegation
Office for Civil Rights; Statement of
Delegation
Center for Scientific Review; Notice of
Closed Meetings
In accordance with Executive Order
13798 Promoting Free Speech and
Religious Liberty (May 4, 2017), 82 FR
21675, and the Attorney General’s
Guidance on Federal Law Protections
for Religious Liberty (October 6, 2017),
notice is hereby given that I have
delegated to the Director of the Office
for Civil Rights (OCR), or his or her
successor, authority over
implementation of and compliance with
the Religious Freedom Restoration Act
(RFRA), 42 U.S.C. 2000bb et seq.,
relating to programs or activities
funded, conducted, or administered by
the Department.
Pursuant to this delegation, the OCR
Director shall have the authority to:
(1) Accept and investigate complaints
filed by individuals or entities alleging
a failure by any departmental
component to comply with RFRA;
(2) conduct RFRA compliance reviews
of departmental programs or activities;
(3) provide technical assistance to
departmental components regarding
RFRA compliance;
(4) evaluate the effectiveness of RFRA
complaint processing by OCR and
provide reports to appropriate oversight
organizations; and
(5) initiate such other actions as may
be necessary to facilitate and ensure
compliance with RFRA.
This authority may be redelegated. If
the OCR Director chooses to redelegate
this authority, the OCR Director will
maintain primary responsibility and
accountability for implementation of
this section. This delegation is effective
upon date of signature. I hereby affirm
and ratify any actions taken by the
Director of OCR or subordinates which
involved the exercise of the authorities
delegated herein prior to the effective
day of this delegation.
daltland on DSKBBV9HB2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice is hereby given that I have
delegated to the Director of the Office
for Civil Rights, or his or her successor,
the authorities vested in the Secretary
concerning enforcement of and
compliance with Section 1303(b)(4) of
the Patient Protection and Affordable
Care Act, 42 U.S.C. 18023(b)(4). This
delegation transfers, but only for the
authorities pursuant to Section
1303(b)(4) and not for other authorities
under Section 1303, the previous
delegation to the Administrator, Centers
for Medicare & Medicaid Services, or his
or her successor, noticed at 76 FR 53903
(Aug. 30, 2011).
Pursuant to this delegation, the OCR
Director shall have the authority to:
(1) Accept and investigate complaints
filed by individuals or entities alleging
a failure to comply with Section
1303(b)(4);
(2) conduct Section 1303(b)(4)
compliance reviews;
(3) provide technical assistance to
departmental components and qualified
health plans regarding Section
1303(b)(4) compliance;
(4) evaluate the effectiveness of
subsection 1303(b)(4) complaint
processing by OCR and provide reports
to appropriate oversight organizations;
and
(5) initiate such other actions as may
be necessary to facilitate and ensure
compliance with Section 1303(b)(4).
This authority may be redelegated. If
the OCR Director chooses to redelegate
this authority, the OCR Director will
maintain primary responsibility and
accountability for implementation of
this section. This delegation is effective
upon date of signature. I hereby affirm
and ratify any actions taken by the
Director of OCR or subordinates which
involved the exercise of the authorities
delegated herein prior to the effective
day of this delegation.
Dated: December 7, 2017.
Eric D. Hargan,
Acting Secretary, Department of Health and
Human Services.
[FR Doc. 2018–00816 Filed 1–18–18; 8:45 am]
BILLING CODE 4153–01–P
Dated: December 7, 2017.
Eric D. Hargan,
Acting Secretary, Department of Health and
Human Services.
[FR Doc. 2018–00818 Filed 1–18–18; 8:45 am]
BILLING CODE 4153–01–P
VerDate Sep<11>2014
17:05 Jan 18, 2018
Jkt 244001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Cognition and Perception Study
Section.
Date: February 8–9, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Baltimore, Inner
Harbor, 222 St. Paul Place, Baltimore, MD
21202.
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Adult Psychopathology and Disorders
of Aging Study Section.
Date: February 12–13, 2018.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, (301) 500–
5829, sechu@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Cellular
Aspects of Diabetes and Obesity Study
Section.
Date: February 13–14, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Antonello Pileggi, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institute of
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00818]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Office for Civil Rights; Statement of Delegation
Notice is hereby given that I have delegated to the Director of the
Office for Civil Rights, or his or her successor, the authorities
vested in the Secretary concerning enforcement of and compliance with
Section 1303(b)(4) of the Patient Protection and Affordable Care Act,
42 U.S.C. 18023(b)(4). This delegation transfers, but only for the
authorities pursuant to Section 1303(b)(4) and not for other
authorities under Section 1303, the previous delegation to the
Administrator, Centers for Medicare & Medicaid Services, or his or her
successor, noticed at 76 FR 53903 (Aug. 30, 2011).
Pursuant to this delegation, the OCR Director shall have the
authority to:
(1) Accept and investigate complaints filed by individuals or
entities alleging a failure to comply with Section 1303(b)(4);
(2) conduct Section 1303(b)(4) compliance reviews;
(3) provide technical assistance to departmental components and
qualified health plans regarding Section 1303(b)(4) compliance;
(4) evaluate the effectiveness of subsection 1303(b)(4) complaint
processing by OCR and provide reports to appropriate oversight
organizations; and
(5) initiate such other actions as may be necessary to facilitate
and ensure compliance with Section 1303(b)(4).
This authority may be redelegated. If the OCR Director chooses to
redelegate this authority, the OCR Director will maintain primary
responsibility and accountability for implementation of this section.
This delegation is effective upon date of signature. I hereby affirm
and ratify any actions taken by the Director of OCR or subordinates
which involved the exercise of the authorities delegated herein prior
to the effective day of this delegation.
Dated: December 7, 2017.
Eric D. Hargan,
Acting Secretary, Department of Health and Human Services.
[FR Doc. 2018-00818 Filed 1-18-18; 8:45 am]
BILLING CODE 4153-01-P
